ArticleClinical pharmacology in drug development2022

Pharmacokinetic/Pharmacodynamic Evaluation of Ivosidenib or Enasidenib Combined With Intensive Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed IDH1/2-Mutant Acute Myeloid Leukemia.

Bin Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.